1. 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. (4th December 2020) Authors: Gonzalez-Martin, Antonio; Chung, Hyun Cheol; Saada-Bouzid, Esma; Yanez, Eduardo; Senellart, Hélène; Cassier, Philippe A; Basu, Bristi; Ghori, Razi; Kubiak, Peter; Smith, Alan; Norwood, Kevin; Lwin, Zarnie Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗